Atea Pharmaceuticals, Inc.AVIRNASDAQ
LOADING
|||
Analyst Sentiment
Analysts are neutral — opinion is divided on direction.
Consensus Rating
Hold
4 analysts·Low coverage
25%
Rating Distribution
Strong Buy
00%
Buy
125%
Hold
250%
Sell
125%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Analysts see significant upside — consensus target 70% higher.
Bear Case
$6.88
+70%
Consensus
$6.88
+70%
Bull Case
$6.88
+70%
Price Range4 analysts
Low
Consensus
High
$6.88
$6.88
Current Target
Current Price
$4.06
Upside to Target
$2.82
Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
2026E$-1.75(1 analysts)
Actual
Estimate
Range (Low–High)
Forward Growth Estimates (YoY)
FY2027
Rev+436.25%
EPS—
Earnings Surprises
Beat rate:67%(8/12 quarters)
Avg surprise:+8.5%
Beat
Miss
Inline
Estimate